cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Y Mabs Therapeutics Inc
3 own
8 watching
Current Price
$4.5
$-0.06
(-1.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
196.51M
52-Week High
52-Week High
20.48
52-Week Low
52-Week Low
2.94
Average Volume
Average Volume
0.28M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization196.51M
icon52-Week High20.48
icon52-Week Low2.94
iconAverage Volume0.28M
iconDividend Yield--
iconP/E Ratio--
What does the Y Mabs Therapeutics Inc do?
Y-mAbs Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody-based therapeutic products for the treatment cancer in the United States. It is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma, as well as other GD2 positive tumors; and omburtamab for the treatment of pediatric patients with central nervous system, leptomeningeal metastases, desmoplastic small round cell tumors, diffuse intrinsic pontine glioma, and other B7-H3 positive tumors. The company has a license and research collaboration agreement with Memorial Sloan Kettering Cancer Center. Y-mAbs Therapeutics, Inc. was founded in 2015 and is headquartered in New York, New York.
Read More
How much money does Y Mabs Therapeutics Inc make?
News & Events about Y Mabs Therapeutics Inc.
Globe Newswire
1day ago
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contactJoseph R. Seidman, Jr. at (877) 779-1414orseidman@bernlieb.com to discuss your rights. NEW YORK, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP...
PR Newswire
1day ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Y-mAbs Therapeutics, Inc. - YMAB PR Newswire NEW YORK, Feb. 6, 2023 NEW YORK, Feb. 6, 2023...
Globe Newswire
1day ago
BENSALEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. ...
Globe Newswire
1day ago
SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that class action lawsuits have commenced on behalf of investors of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB), Bioventus Inc. (NASDAQ: BVS), and Fate Therapeutics, Inc. (NASDAQ: FATE), and Invivyd, ...
Globe Newswire
2days ago
LOS ANGELES, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (GPM) reminds investors of the upcomingMarch 20, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Y-mAbs Therapeutics, Inc. (Y-mAbs or the ...
Frequently Asked Questions
Frequently Asked Questions
What is Y Mabs Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Y Mabs Therapeutics Inc shares?
plus_minus_icon
How can I buy Y Mabs Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Y Mabs Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Y Mabs Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Y Mabs Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Y Mabs Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Y Mabs Therapeutics Inc?
plus_minus_icon
What percentage is Y Mabs Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Y Mabs Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.5
$-0.06
(-1.32%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00